Skip to main content

The role of parenteral nutrition in patients with malignant bowel obstruction

Supportive Care in Cancer volume 27, pages 4393–4399 (2019)Cite this article

Abstract

Purpose

The role of parenteral nutrition in the treatment of malignant bowel obstruction is underestimated since palliative literature mainly focuses on gastric aspiration, nothing per os and antisecretory therapy. The purpose of this review is the appraisal of the literature with a focus on the potential contribution of parenteral nutrition.

Methods

Literature included in a recent meta-analysis and in a Cochrane review on parenteral nutrition in malignant bowel obstruction and updated through PUBMED until March 2019 has been reviewed.

Results

Prompt withholding of food intake, nasogastric aspiration and then the use of antisecretory agents represent the milestones of treatment which are applied to all patients with malignant bowel obstruction. After this initial approach, excluding few surgical patients and those defined as imminently dying, there is a heterogeneous group of patients achieving a benefit in a few days but with a prompt recurrence of symptoms as they attempt to reassume some food intake. Parenteral nutrition in hospital or at home addresses to these patients provided their life expectancy is likely to depend on progressive nutritional deterioration due to the prolonged starvation more than on the tumour spread. These patients on home parenteral nutrition can survive a few months with some indefinite benefit on quality of life whereas untreated patients have a survival of few weeks.

Conclusion

Parenteral nutrition should be considered in selected patients who benefit from standard palliative treatment of malignant obstruction and are obliged to maintain a total bowel rest for weeks or months.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Anthony T, Baron T, Mercadante S, Green S, Chi D, Cunningham J, Herbst A, Smart E, Krouse RS (2007) Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction. J Pain Symptom Manag 34:S49–S59

    Google Scholar 

  2. Ripamonti C, Bruera E (2002) Palliative management of malignant bowel obstruction. Int J Gynecol Cancer 12:135–143

    PubMed  Google Scholar 

  3. Ripamonti C, Easson AM, Gerdes H (2008) Management of malignant bowel obstruction. Eur J Cancer 44(8):1105–1015

    PubMed  Google Scholar 

  4. Ripamonti C, Twycross R, Baines M, Bozzetti F, Capri S, de Conno F, Gemlo B, Hunt T, Hans-B. K, Mercadante S, Schaerer R, Wilkinson P, Working Group of the European Association for Palliative Care (2001) Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 9:223–233

    CAS  PubMed  Google Scholar 

  5. Henry JC, Pouly S, Sullivan R, Sharif S, Klemanski D, Abdel-Misih S, Arradaza N, Jarjoura D, Schmidt C, Bloomston M (2012) A scoring system for the prognosis and treatment of malignant bowel obstruction. Surgery 152(4):747–756

    PubMed  PubMed Central  Google Scholar 

  6. Laval G, Marcelin-Benazech B, Guirimand F et al (2014) French Society for Palliative Care; French Society for Digestive Surgery; French Society for Gastroenterology; French Association for Supportive Care in oncology; French Society for Digestive Cancer. Recommendations for bowel obstruction with peritoneal carcinomatosis. J Pain Symptom Manag 48(1):75–91

    Google Scholar 

  7. Martinez Castro P, Vargas L, Mancheño A et al (2017) Malignant bowel obstruction in relapsed ovarian cancer with peritoneal carcinomatosis: an occlusive state. Int J Gynecol Cancer 27(7):1367–1372

    PubMed  Google Scholar 

  8. Paul Olson TJ, Pinkerton C, Brasel KJ, Schwarze ML (2014) Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review. JAMA Surg 149(4):383–392

    PubMed  PubMed Central  Google Scholar 

  9. Ferguson HJ, Ferguson CI, Speakman J et al (2015) Management of intestinal obstruction in advanced malignancy. Ann Med Surg (Lond) 4(3):264–270

    Google Scholar 

  10. Naghibi M, Smith TR, Elia M (2015) A systematic review with meta-analysis of survival, quality of life and cost-effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction. Clin Nutr 34(5):825–837

    CAS  PubMed  Google Scholar 

  11. Sowerbutts AM, Lal S, Sremanakova J et al (2018) Home parenteral nutrition for people with inoperable malignant bowel obstruction. Cochrane Database Syst Rev 8:CD012812. https://doi.org/10.1002/14651858.CD012812

    Article  PubMed  Google Scholar 

  12. Tuca A, Guell E, Martinez-Losada E et al (2012) Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution. Cancer Manag Res 4:159–169

    PubMed  PubMed Central  Google Scholar 

  13. Ketcham AS, Hoye RC, Pilch YH, Morton DL (1970) Delayed intestinal obstruction following treatment for cancer. Cancer 25(2):406–410

    CAS  PubMed  Google Scholar 

  14. Osteen RT, Guyton S, Steele G Jr, Wilson RE (1980) Malignant intestinal obstruction. Surgery 87(6):611–615

    CAS  PubMed  Google Scholar 

  15. Legendre H, Vahhuyse F, Caroli-Bose FX et al (2001) Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction. Eur J Surg Oncol 27:364–367

    CAS  PubMed  Google Scholar 

  16. Kim DH, Kim B, Choi JH, Park SJ, Hong SP, Cheon JH, Kim WH, Kim TI (2016) Tumor characteristics associated with malignant large bowel obstruction in stage IV colorectal cancer patients undergoing chemotherapy. Int J Color Dis 31:1767–1774

    Google Scholar 

  17. Cousins SE, Tempest E, Feuer DJ (2016) Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev 1:CD002764

    Google Scholar 

  18. Chakraborty A, Selby D, Gardiner K, Myers J, Moravan V, Wright F (2011) Malignant bowel obstruction: natural history of a heterogeneous patient population followed prospectively over two years. J Pain Symptom Manag 41(2):412–420

    Google Scholar 

  19. Mooney SJ, Winner M, Hershman DL, Wright JD, Feingold DL, Allendorf JD, Neugut AI (2013) Bowel obstruction in elderly ovarian cancer patients: a population based study. Gynecol Oncol 129(1):107–112

    PubMed  Google Scholar 

  20. Lilley EJ, Scott JW, Goldberg JE et al (2017) Survival, healthcare utilization, and end-of-life care among older adults with malignancy-associated bowel obstruction: comparative study of surgery, venting gastrostomy, or medical management. Ann Surg 267(4):692–699

    Google Scholar 

  21. Winner M, Mooney SJ, Hershman DL, Feingold DL, Allendorf JD, Wright JD, Neugut AI (2013) Management and outcomes of bowel obstruction in patients with stage IV colon cancer: a population-based cohort study. Dis Colon Rectum 56(7):834–843

    PubMed  PubMed Central  Google Scholar 

  22. Woolfson RG, Jennings K, Whalen GF (1997) Management of bowel obstruction in patients with abdominal cancer. Arch Surg 132:1093–1097

    CAS  PubMed  Google Scholar 

  23. Diver E, O’Connor O, Garrett L et al (2013) Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement. Gynecol Oncol 129(2):332–335

    PubMed  Google Scholar 

  24. Chouhan J, Gupta R, Ensor J et al (2016) Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction. Cancer Med 5(2):239–247

    PubMed  Google Scholar 

  25. Brard L, Weitzen S, Strubel-Lagan SL et al (2006) The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients. Gynecol Oncol 103(1):176–180

    PubMed  Google Scholar 

  26. Glare P, Pereira G, Kristjanson LJ, Tattersall M, Stockler M (2004) Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer 12(6):432–440

    PubMed  Google Scholar 

  27. Baines M, Oliver DJ, Carter RL (1985) Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study. Lancet. 2(8462):990–993

    CAS  PubMed  Google Scholar 

  28. Ripamonti C, Mercadante S, Groff L, Zecca E, de Conno F, Casuccio A (2000) Role of octreotide, scopolamine butylbromide and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manag 19:23–34

    CAS  Google Scholar 

  29. Mercadante S, Ripamonti C, Casuccio A, Zecca E, Groff L (2000) Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer 8:188–191

    CAS  PubMed  Google Scholar 

  30. Mystakidou K, Tsilika E, Kalaidopoulou O, Chondros K, Georgaki S, Papadimitriou L (2002) Comparison of octreotide administration vs. conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double-blind, controlled clinical trial. Anticancer Res 22(2B):1187–1192

    CAS  PubMed  Google Scholar 

  31. Tunca JC, Buchler DA, Mack EA, Ruzicka FF, Crowley JJ, Carr WF (1981) The management of ovarian-cancer caused bowel obstruction. Gynecol Oncol 12:186–192

    CAS  PubMed  Google Scholar 

  32. Lund B, Hansen M, Lundvall F et al (1989) Intestinal obstruction in patients with advanced carcinoma of the ovaries treated with combination chemotherapy. Surg Gynecol Obstet 169(3):213–218

    CAS  PubMed  Google Scholar 

  33. Bais JMJ, Schilthuis MS, Slors JFM, Lammes FB (1995) Intestinal obstruction in patients with advanced ovarian cancer. Int J Gynecol Cancer 5(5):346–350

    PubMed  Google Scholar 

  34. Jong P, Sturgeon J, Jamieson CG (1995) Benefit of palliative surgery for bowel obstruction in advanced ovarian cancer. Can J Surg 38(5):454–457

    CAS  PubMed  Google Scholar 

  35. Pothuri B, Vaidya A, Aghajanian C, Venkatraman E, Barakat RR, Chi DS (2003) Palliative surgery for bowel obstruction in recurrent ovarian cancer: an updated series. Gynecol Oncol 89(2):306–313

    PubMed  Google Scholar 

  36. Chi DS, Phaëton R, Miner TJ et al (2009) A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer. Oncologist 14(8):835–839

    PubMed  Google Scholar 

  37. Kim K, Kang SB, Kim MJ et al (2009) Factors associated with successful palliation and improved survival in patients with malignant bowel obstruction caused by ovarian cancer. J Am Med Wom Assoc 2(2):54–58

    Google Scholar 

  38. Kolomainen DF, Daponte A, Barton DPJ, Pennert K, Ind TEJ, Bridges JE, Shepherd JH, Gore ME, Kaye SB, Riley J (2012) Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC). Gynecol Oncol 125(1):31–36

    CAS  PubMed  Google Scholar 

  39. Krebs HB, Goplerud DR (1983) Surgical management of bowel obstruction in advanced ovarian cancer. Obstet Gynecol 61:327–330

    CAS  PubMed  Google Scholar 

  40. Gemlo B, Rayner AA, Lewis B, Wong A, Viele CS, Ungaretti JR et al (1988) Home support of patients with end-stage malignant bowel obstruction using hydration and venting gastrostomy. Am J Surg 152:100–104

    Google Scholar 

  41. Rubin SC, Hoskins WJ, Benjamin I, Lewis JL (1989) Palliative surgery for intestinal obstruction inadvanced ovarian cancer. Gynecol Oncol 34:16–19

    CAS  PubMed  Google Scholar 

  42. Porzio G, Aielli F, Verna L, Galletti B, Shoja E, Razavi G, Ficorella C (2011) Can malignant bowel obstruction in advanced cancer patients be treated at home? Support Care Cancer 19(3):431–433

    PubMed  Google Scholar 

  43. Mercadante S (1995) Bowel obstruction in home-care cancer patients: 4 years experience. Support Care Cancer 3:190–193

    CAS  PubMed  Google Scholar 

  44. Mangili G, Franchi M, Mariani A, Zanaboni F, Rabaiotti E, Frigerio L, Bolis PF, Ferrari A (1996) Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynecol Oncol 61(3):345–348

    CAS  PubMed  Google Scholar 

  45. August DA, Thorn D, Fisher RL, Welchek CM (1991) Home parenteral nutrition for patients with inoperable malignant bowel obstruction. J Parenter Enter Nutr 15:323–327

    CAS  Google Scholar 

  46. Bozzetti F, Cozzaglio L, Biganzoli E et al (2002) Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr 21:281–288

    CAS  PubMed  Google Scholar 

  47. Chermesh I, Mashiach T, Amit A, Haim N, Papier I, Efergan R, Lachter J, Eliakim R (2011) Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks? Med Oncol 28:83–88

    CAS  PubMed  Google Scholar 

  48. Duerksen DR, Ting E, Thomson P, McCurdy K, Linscer J, Larsen-Celhar S, Brennenstuhl E (2004) Is there a role for TPN in terminally ill patients with bowel obstruction? Nutrition 20:760–763

    PubMed  Google Scholar 

  49. Mercadante S (1995) Parenteral nutrition at home in advanced cancer patients. J Pain Symptom Manag 10:476–480

    CAS  Google Scholar 

  50. Pasanisi F, Orban A, Scalfi L, Alfonsi L, Santarpia L, Zurlo E, Celona A, Potenza A, Contaldo F (2001) Predictors of survival in terminal-cancer patients with irreversible bowel obstruction receiving home parenteral nutrition. Nutrition 17:581–584

    CAS  PubMed  Google Scholar 

  51. Pironi L, Ruggeri E, Tanneberger S, Giordani S, Pannuti F, Miglioli M (1997) Home artificial nutrition in advanced cancer. J R Soc Med 90(11):597–603

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Soo I, Gramlich L (2008) Use of parenteral nutrition in patients with advanced cancer. Appl Physiol Nutr Metab 33:102–106

    CAS  PubMed  Google Scholar 

  53. Cotogni P, De Carli L, Passera R et al (2017) Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Med 6:1799–1806

    PubMed  PubMed Central  Google Scholar 

  54. Santarpia L, Alfonsi L, Pasanisi F, de Caprio C, Scalfi L, Contaldo F (2006) Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition 22:355–360

    PubMed  Google Scholar 

  55. Keane N, Fragkos K, Patel P et al (2018) Performance status, prognostic scoring, and parenteral nutrition requirements predict survival in patients with advanced cancer receiving home parenteral nutrition. Nutr Cancer 70(1):73–82

    PubMed  Google Scholar 

  56. King LA, Carson LF, Konstantinides N, House MS, Adcock LL, Prem KA, Twiggs LB, Cerra FB (1993) Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience? Gynecol Oncol 51:377–382

    CAS  PubMed  Google Scholar 

  57. Oh SY, Jun HJ, Park SJ, Park IK, Lim GJ, Yu Y, Cho SJ, Song A (2014) A randomized phase II study to assess the effectiveness of fluid therapy or intensive nutritional support on survival in patients with advanced cancer who cannot be nourished via enteral route. J Palliat Med 17(11):1266–1270

    PubMed  Google Scholar 

  58. Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36(1):11–48

    PubMed  Google Scholar 

  59. Bozzetti F, Santarpia L, Pironi L, Thul P, Klek S, Gavazzi C, Tinivella M, Joly F, Jonkers C, Baxter J, Gramlich L, Chicharro L, Staun M, van Gossum A, Lo Vullo S, Mariani L (2014) The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients. Ann Oncol 25(2):487–493

    CAS  PubMed  Google Scholar 

  60. Bozzetti F, Cotogni P, Lo Vullo S, Pironi L, Giardiello D, Mariani L (2015) Development and validation of a nomogram to predict survival in incurable cachectic cancer patients home parenteral nutrition. Ann Oncol 26:2335–2340

    CAS  PubMed  Google Scholar 

  61. Selby D, Wright F, Stilos K, Daines P, Moravan V, Gill A, Chakraborty A (2010) Room for improvement? A quality-of-life assessment in patients with malignant bowel obstruction. Palliat Med 24(1):38–45

    CAS  PubMed  Google Scholar 

  62. Finocchiaro C, Gervasio S, Agnello E et al (2002) Multicentric study on home parenteral nutrition in advanced cancer patients. Rivista italiana di Nutrizione Parenterale ed Enterale 20:98–107

    Google Scholar 

  63. Bozzetti F, Amadori D, Bruera E et al (1996) Guidelines on artificial nutrition versus hydration in terminal cancer patients. Nutrition 12:163–167

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, University of Milan, via Festa del Perdono, 20100, Milan, Italy

    Federico Bozzetti

Authors
  1. Federico Bozzetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Federico Bozzetti.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bozzetti, F. The role of parenteral nutrition in patients with malignant bowel obstruction. Support Care Cancer 27, 4393–4399 (2019). https://doi.org/10.1007/s00520-019-04948-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-019-04948-1

Keywords

  • Home parenteral nutrition
  • Malignant bowel obstruction
  • Intravenous nutrition
  • Palliative therapy in cancer